pharmaphorum

NOVEMBER 7, 2022

This month, we highlight new appointments from Lumeris, Lineage Cell Therapeutics, 1910 Genetics, and ADC Therapeutics. . ” Patrick Genestin, 1910 Genetics . “I am excited to join 1910 Genetics at such a pivotal time for the company,” Genestin said. Ben Grabski, Lumeris.

Life Science 105

Life Science Genetics Business Development Marketing 105

XTalks

JANUARY 5, 2022

Ayesha also discussed some of the predicted trends in the life sciences for 2022. These include the continued promise of RNA-based vaccines as well as therapeutics based on RNA editing approaches for the treatment of various conditions including rare genetic diseases. Key Trends in the Life Sciences to Look Forward to in 2022.

Life Science 52

Life Science RNA Vaccination Vaccine 52

XTalks

SEPTEMBER 27, 2023

With their extensive genetic engineering capabilities, they are paving the way for potentially better and safer treatments for conditions including blood cancers such as multiple myeloma, solid tumors like breast and ovarian cancer, and rare genetic liver diseases. Scientists working at Poseida Therapeutics.

Life Science 59

Life Science Genetic Engineering Engineer Gene Therapy 59

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

XTalks

SEPTEMBER 29, 2021

Life science workers are one of the most common areas of work that could not eliminate all visits to the office or lab during the COVID-19 pandemic. Additionally, these life science companies are now trying to find the new normal for many of their employees to accommodate the new lifestyle they have embraced.

Life Science 122

Life Science HR Scientist Genetic Disease 122

XTalks

SEPTEMBER 14, 2022

In this episode, Ayesha discussed the FDA approval of Sanofi’s enzyme replacement therapy Xenpozyme for the treatment of non-central nervous system (non-CNS) manifestations of acid sphingomyelinase deficiency (ASMD), a rare genetic lysosomal storage disease, in adults and pediatric patients.

Life Science 90

Life Science FDA Approval Insulin Drugs 90

Drug Discovery World

MARCH 6, 2023

The post Institiute gives a boost to five new life science start-ups appeared first on Drug Discovery World (DDW). In becoming a part of the Venture Lab programme, the early-stage companies also get an exclusive opportunity to apply for €1.4 million in follow-up funding through BII’s Venture House program.

Life Science 52

Life Science RNA Drugs Business Development 52

XTalks

MARCH 28, 2024

Duvyzat, a histone deacetylase (HDAC) inhibitor that works to reduce inflammation and muscle loss, is the first nonsteroidal drug approved to treat patients with all genetic variants of DMD. According to the FDA, life expectancy for those with DMD has increased over the years, with some patients surviving beyond 30 years.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

Scienmag

JULY 4, 2022

Medical and life science researchers will benefit from the most comprehensive atlas yet of genetic data on zebrafish, newly published research suggests. The atlas will help researchers to better study conditions from various types of cancer (e.g. skin cancer), heart disease, and neurodegeneration.

Genetics 61

Genetics Research Life Science 61

Pharmaceutical Technology

JUNE 6, 2023

Alkeus Pharmaceuticals has raised $150m in Series B financing to support the registration and launch of gildeuretinol (ALK-001) to treat Stargardt disease, a genetic cause of blindness in children and young adults. The genetic cause is well characterised, but to date there is no effective treatment.

Genetics 279

Genetics Life Science Trials Clinical Development 279

XTalks

MARCH 2, 2022

The editorial team discussed the encouraging growth seen in recent years in rare disease clinical research in the life science industries, providing hope for improved diagnosis, care and treatments for patients with rare diseases. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Clinical Trials Clinical Trials Trials 52

XTalks

JUNE 23, 2022

Amvuttra RNAi Therapeutic Wins FDA Approval for Rare Genetic Protein Disorder. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Read the full articles here: Eli Lilly’s Olumiant Wins FDA Approval as First Systemic Treatment for Alopecia Areata.

Life Science 52

Life Science FDA Approval Protein Drugs 52

XTalks

SEPTEMBER 22, 2022

can act on existing genetic mutations to trigger inflammation and the development of cancer. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. The research findings revealed that people who live in polluted areas have a higher risk of lung cancer, and that particulate matter smaller than 2.5

Life Science 52

Life Science Scientist Development Genetics 52

BioTech 365

SEPTEMBER 10, 2020

10, 2020 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive … Continue reading →

Life Science 40

Life Science Genetics Medicine 40

The Pharma Data

JANUARY 31, 2021

Illumina , the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. The focus will be on building life science startups specializing in genomics.

Life Science 52

Life Science Genome Genomics Reagent 52

Pharmaceutical Technology

FEBRUARY 2, 2023

Last December, GSK and Wave Life Sciences entered a strategic partnership to drive the discovery and development of oligonucleotide therapies for new genetic targets. The post US FDA approves GSK’s Jesduvroq to treat anaemia of CKD appeared first on Pharmaceutical Technology.

FDA Approval 264

FDA Approval Life Science Genetics Trials 264

STAT News

SEPTEMBER 12, 2022

In the life sciences industry, where company names derived from “biology” or “genetics” are a dime a dozen, it helps to have a brand that stands out. Pretzel Therapeutics is one of this year’s more creative gambits, launching Monday with $72.5 Continue to STAT+ to read the full story…

Genetic Disease 98

Genetic Disease Life Science Genetics Branding 98

Pharmaceutical Technology

MAY 24, 2023

The AMP programme is a public-private partnership between a number of biopharmaceutical and life sciences companies, the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH), along with non-profit and other organisations.

Gene Therapy 242

Gene Therapy Gene Development Manufacturing 242

XTalks

SEPTEMBER 15, 2021

With RNA being the popular new “it” molecule in genetic research, Ayesha discusses Eli Lilly’s new partnership with biotech company ProQR to develop RNA-based therapeutics in this episode. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. New Study Shows Less May Be More.

RNA 52

RNA Life Science Development Genetics 52

XTalks

SEPTEMBER 30, 2020

The two studies were recently published online in the journal Science, both of which were led by Jean-Laurent Casanova, an infectious disease geneticist at Rockefeller University. Casanova’s lab is now searching for the genetic driver behind the autoantibodies. Autoimmune Attack and COVID-19 Symptom Severity.

Antibody 135

Antibody Genetics Research In-Vitro 135

Drug Discovery Today

AUGUST 5, 2021

(Oslo, August 5, 2021) Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced the first publication from the comprehensive HumGut microbiome database has appeared in the leading scientific journal Microbiome.

Genetic Analysis 40

Genetic Analysis Genome Genomics Genetics 40

Pharmaceutical Technology

MAY 22, 2023

This new facility complements the bioprocess design centre and customer experience centre, the two operational lab facilities of Thermo Fisher with the latest life science, analytical, and bioprocessing technologies. The bioprocess design centre offers expertise in bioprocessing and process scale-up.

Genetic Analysis 147

Genetic Analysis Manufacturing Drugs Vaccination 147

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

SEPTEMBER 12, 2023

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

Pharmaceutical Technology

JANUARY 12, 2023

Under the research partnership deal, the companies will develop new precision genetic medicines for a severe form of genetic dilated cardiomyopathy (DCM). Solid Biosciences stated that the partnership boosts its scientific capabilities along with commercial potential in cardiac therapy.

RNA 130

RNA Gene Therapy Genetics Genetic Disease 130

XTalks

JUNE 20, 2022

Alnylam Pharmaceuticals, a leading RNA interference (RNAi) therapeutics biopharmaceutical company, announced it received approval from the US Food and Drug Administration (FDA) for its RNAi therapeutic Amvuttra (vutrisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated (ATTR) amyloidosis in adults.

FDA Approval 98

FDA Approval Protein Genetics RNA 98

Medical Xpress

MARCH 21, 2023

An international study led by the Molecular Physiology Laboratory at the UPF Department of Medicine and Life Sciences (MELIS) identifies new genes that modulate the toxicity of the protein β-amyloid, responsible for causing Alzheimer's disease.

Protein 98

Protein Gene Life Science Research 98

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration.

Gene Therapy 256

Gene Therapy Gene Development Manufacturing 256

Scienmag

JUNE 7, 2021

Credit: Autobahn Labs Cold Spring Harbor Laboratory (CSHL) is collaborating with Autobahn Labs, a new life sciences incubator, to catalyze the Laboratory’s early-stage discovery programs into spin-out companies that commercialize transformational new therapies. Autobahn will provide […].

Genetic Disease 52

Genetic Disease Life Science Genetics Research 52

XTalks

JANUARY 27, 2023

The website brings awareness for facial angiofibroma, an aspect of the rare genetic disease tuberous sclerosis complex (TSC). Nobelpharma America, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, has launched an educational website called Face Forward.

Life Science 98

Life Science Genetic Disease FDA Approval Marketing 98

World of DTC Marketing

JANUARY 24, 2022

A group of early-stage life science investors and biotech CEOs joined together with a prominent patient advocate to speak out against H.R.3, The panel was hosted by the life sciences venture capital coalition Incubate and held at the National Press Club. Only about $2.2 3, known as the Lower Drug Costs Now Act.

Life Science 225

Life Science Drugs Genetic Disease Development 225

Drug Discovery World

FEBRUARY 20, 2024

AI-driven solutions aim to enhance the speed, accuracy and efficiency of research and development processes within the life sciences industry. The post Drug discovery informatics market predicted to grow 12.6% by 2028 appeared first on Drug Discovery World (DDW).

Marketing 52

Marketing Drugs Life Science Genome 52

Drug Discovery World

JUNE 19, 2023

Cystic fibrosis is a progressive genetic disease that affects the lungs, pancreas and other organs. Anoat will use the funds to conduct additional in vivo and in vitro pharmacology assessments and select a lead candidate.

Development 52

Development Life Science In-Vivo In-Vitro 52

XTalks

MAY 17, 2023

The announcement of its clinical trial portfolio is an important milestone, bringing people with rare genetic diseases one step closer to approved therapies.” Of the more than 10,000 rare diseases, more than 80 percent are caused by genetic defects. In the US, more than 30 million people live with a rare disease.

Gene Therapy 98

Gene Therapy Clinical Trials Clinical Trials Gene 98

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

Pharmaceutical Technology

FEBRUARY 16, 2023

The biology of ageing Ageing is an intensely complex syndrome influenced by environmental, genetic, and epigenetic factors. Previous research by Cynthia Kenyon et al revealed that ageing and its related diseases can be influenced through genetic mutation or direct intervention (eg. Can we extend human life?

Insulin 130

Insulin DNA Genetics Life Science 130

Drug Discovery World

MAY 11, 2023

Fundraising and investment are a core pillar of not just BioTrinity events but of the drug discovery industry at large, so events such as Tuesday’s keynote, Investment Trends for the Life Sciences Industry, are critical for members of the industry.

Life Science 52

Life Science Genetics Vaccination Vaccine 52